BR0314838A - Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida - Google Patents

Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida

Info

Publication number
BR0314838A
BR0314838A BR0314838-6A BR0314838A BR0314838A BR 0314838 A BR0314838 A BR 0314838A BR 0314838 A BR0314838 A BR 0314838A BR 0314838 A BR0314838 A BR 0314838A
Authority
BR
Brazil
Prior art keywords
controlled release
release system
tablets
preparing
preparing temozolomide
Prior art date
Application number
BR0314838-6A
Other languages
English (en)
Inventor
Yongfeng Wang
Dan Fei
Original Assignee
Tianjin Tasly Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Group Co Ltd filed Critical Tianjin Tasly Group Co Ltd
Publication of BR0314838A publication Critical patent/BR0314838A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

"SISTEMA DE LIBERAçãO CONTROLADA, E, PROCESSO PARA PREPARAR COMPRIMIDOS DE LIBERAçãO CONTROLADA DE TEMOZOLOMIDA". A presente invenção refere-se a um sistema de liberação controlada, particularmente a um sistema de liberação controlada contendo temozolomida.
BR0314838-6A 2002-09-29 2003-09-29 Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida BR0314838A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN02131347 2002-09-29
PCT/CN2003/000838 WO2004028534A1 (fr) 2002-09-29 2003-09-29 Systeme de liberation controlee contenant temozolomide

Publications (1)

Publication Number Publication Date
BR0314838A true BR0314838A (pt) 2005-08-09

Family

ID=32034727

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314838-6A BR0314838A (pt) 2002-09-29 2003-09-29 Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida

Country Status (15)

Country Link
US (1) US8821913B2 (pt)
EP (1) EP1550444A4 (pt)
JP (1) JP4879488B2 (pt)
KR (1) KR100979217B1 (pt)
CN (1) CN100366249C (pt)
AU (1) AU2003272857B2 (pt)
BR (1) BR0314838A (pt)
CA (1) CA2500387C (pt)
MX (1) MXPA05003315A (pt)
NZ (1) NZ539527A (pt)
PL (1) PL218200B1 (pt)
RU (1) RU2322979C2 (pt)
UA (1) UA87813C2 (pt)
WO (1) WO2004028534A1 (pt)
ZA (1) ZA200502858B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100431608C (zh) * 2005-04-06 2008-11-12 山东蓝金生物工程有限公司 一种含四嗪类化合物的抗实体肿瘤药物组合物
CN101559037B (zh) * 2008-04-16 2013-01-30 北京京卫燕康药物研究所有限公司 用于静脉和脑内注射的两元溶液型制剂
US9316632B2 (en) * 2009-03-17 2016-04-19 Marshall University Research Corporation Methods of screening chemotherapeutic agents and treating cancer
WO2010144881A1 (en) * 2009-06-12 2010-12-16 The General Hospital Corporation Treatment of meningeal and neural diseases
CN101869551B (zh) * 2010-06-28 2012-04-18 江苏奥赛康药业股份有限公司 一种替莫唑胺冻干制剂
CN102406627B (zh) * 2011-11-22 2013-03-13 温州医学院 一种层层组装马赛克结构药物缓释植片
CN104324014A (zh) * 2014-11-25 2015-02-04 深圳市健元医药科技有限公司 一种含醋酸卡泊芬净的药物组合物缓释植入剂及其制备
AU2016298210B2 (en) 2015-07-28 2021-12-09 Board Of Regents, The University Of Texas System Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
CN108403656A (zh) * 2018-04-03 2018-08-17 孙奉生 一种用于治疗多形性胶质母细胞瘤的替莫唑胺多晶型胶囊
US20200129435A1 (en) * 2018-10-24 2020-04-30 Uvic Industry Partnerships Inc. Composition for delivering a therapeutic agent and methods for making and using

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757128A (en) * 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4888176A (en) * 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
UA29466C2 (uk) * 1993-01-14 2000-11-15 Канзер Рісерч Кампейн Технолоджі, Лтд Фармацевтична композиція з антипухлинною активністю
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
DE19608423A1 (de) * 1996-03-05 1997-09-11 Merck Patent Gmbh Implantate mit phasenweiser Arzneistoffabgabe
WO1999011272A1 (en) * 1997-09-02 1999-03-11 Johns Hopkins University School Of Medicine Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
CN1345240A (zh) * 1999-03-30 2002-04-17 先灵公司 用替莫唑胺改善癌症治疗
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
JP4144980B2 (ja) * 1999-09-22 2008-09-03 オリンパス株式会社 ステージ装置
US6647412B1 (en) 2000-06-23 2003-11-11 Nokia Internet Communications Inc. Method and network for propagating status information
CA2420854C (en) * 2000-09-01 2013-07-30 Palmaya Pty Ltd Slow release pharmaceutical preparation and method of administering of same
US20020128228A1 (en) * 2000-12-01 2002-09-12 Wen-Jen Hwu Compositions and methods for the treatment of cancer

Also Published As

Publication number Publication date
RU2322979C2 (ru) 2008-04-27
KR100979217B1 (ko) 2010-08-31
AU2003272857B2 (en) 2008-08-07
UA87813C2 (ru) 2009-08-25
CA2500387C (en) 2012-07-10
US8821913B2 (en) 2014-09-02
JP2006504698A (ja) 2006-02-09
MXPA05003315A (es) 2005-10-18
EP1550444A1 (en) 2005-07-06
KR20050072094A (ko) 2005-07-08
EP1550444A4 (en) 2010-05-26
CN1600307A (zh) 2005-03-30
CA2500387A1 (en) 2004-04-08
WO2004028534A1 (fr) 2004-04-08
PL218200B1 (pl) 2014-10-31
PL376130A1 (en) 2005-12-27
NZ539527A (en) 2007-10-26
CN100366249C (zh) 2008-02-06
JP4879488B2 (ja) 2012-02-22
RU2005113282A (ru) 2005-10-10
US20050244494A1 (en) 2005-11-03
ZA200502858B (en) 2008-01-30
AU2003272857A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
BR0008301B1 (pt) processo para a fabricaÇço de compostos, e, compostos.
BR0205837B1 (pt) processo para a montagem de um sistema de embreagem.
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
SI1467706T1 (sl) Dermalni sistem za nanašanje derivatov aminolevulinske kisline
BR0211391B1 (pt) processo para preparaÇço de 4-aminodifenilaminas.
BR0310115B1 (pt) processo para preparaÇço de dinitrilas de Ácido fenilmalânico.
BR0314838A (pt) Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
BR0301667B1 (pt) processo para a preparaÇço de polÍmeros em emulsço com pureza elevada.
BR0315969B1 (pt) processo para preparaÇço de 1,3-propanodiol.
WO2002030870A3 (de) Substituierte c-cyclohexylmethylamin-derivate
BR0215709A (pt) Processo para a preparação de cefdinir
BR9917475B1 (pt) processo para a manufatura de compostos, e, modificação do processo.
BR0212772A (pt) Processo para a preparação de repaglinida
BR9808642A (pt) Processo para preparar eprosartan
BR0209842A (pt) Processo para a preparação de imipenem
BR9808664A (pt) Processo para preparar eprosartan
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
BR0006843A (pt) Dispositivo de embreagem
EP1565448A4 (en) PROCESS FOR THE PREPARATION OF 10H-DIBENZOçB, F] ç1,4] THIAZEPIN-11-ON
BR0101437A (pt) Método para preparar um ciclopropeno
BRPI0500102A (pt) Adesivos contendo grupos de ortoésteres
IL164901A0 (en) Optically active beta-aminoketones, optically active 1,3-aminoalcohols and processes for preparing them
BR0311761A (pt) Processo para a preparação de 4,6-dicloro-5-fluorpirimidina
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TASLY HOLDING GROUP CO., LTD. (CN)

B25G Requested change of headquarter approved

Owner name: TASLY HOLDING GROUP CO., LTD. (CN)

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REFERENTE AO DESPACHO 7.5, PUBLICADO NA RPI 2411 DE 21/03/2017, PARA CORRECAO DE DOCUMENTOS.

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL